These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7471610)

  • 1. Amrinone metabolism.
    Kullberg MP; Freeman GB; Biddlecome C; Alousi AA; Edelson J
    Clin Pharmacol Ther; 1981 Mar; 29(3):394-401. PubMed ID: 7471610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
    Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
    J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between amrinone plasma concentration and cardiac index.
    Edelson J; LeJemtel TH; Alousi AA; Biddlecome CE; Maskin CS; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jun; 29(6):723-8. PubMed ID: 7226703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of amrinone in animals.
    Baker JF; Chalecki BW; Benziger DP; O'Melia PE; Clemans SD; Edelson J
    Drug Metab Dispos; 1982; 10(2):168-72. PubMed ID: 6124404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the bipyridines amrinone and milrinone.
    Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
    Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose proportionality of amrinone.
    Edelson J; Park GB; Angellotti J; Kershner RP; Ryan JJ; McMahon FG
    Clin Pharmacol Ther; 1983 Aug; 34(2):190-4. PubMed ID: 6872413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pharmacodynamics and pharmacokinetics of oral amrinone.
    Benotti JR; Lesko LJ; McCue JE
    J Clin Pharmacol; 1982 Oct; 22(10):425-32. PubMed ID: 7174852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related amrinone pharmacokinetics in a pediatric population.
    Allen-Webb EM; Ross MP; Pappas JB; McGough EC; Banner W
    Crit Care Med; 1994 Jun; 22(6):1016-24. PubMed ID: 8205809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amrinone for congestive heart failure.
    Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental and clinical pharmacokinetics of amrinone].
    Padrini R; Miglioli PA; Casiglia E; Piovan D; Ferrari M
    Cardiologia; 1982; 27(1):103-6. PubMed ID: 6927443
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the acetylator phenotype on amrinone pharmacokinetics.
    Hamilton RA; Kowalsky SF; Wright EM; Cernak P; Benziger DP; Stroshane RM; Edelson J
    Clin Pharmacol Ther; 1986 Dec; 40(6):615-9. PubMed ID: 3780123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH; Kapur PA
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and pharmacodynamics of newer inotropic agents.
    Rocci ML; Wilson H
    Clin Pharmacokinet; 1987 Aug; 13(2):91-109. PubMed ID: 3304772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral amrinone on platelet function and survival.
    Brandt JT; Miller L; Hermiller J; Unverferth DV; Leier CV
    Clin Pharmacol Ther; 1984 Aug; 36(2):260-4. PubMed ID: 6744783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
    Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1984 Jul; 52(1):38-48. PubMed ID: 6743422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog.
    Kullberg MP; Dorrbecker B; Lennon J; Rowe E; Edelson J
    J Chromatogr; 1980 Jan; 187(1):264-70. PubMed ID: 7358819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.